Population-level impact of initiating pharmacotherapy and linking to care people with opioid use disorder at inpatient medically managed withdrawal programs: an effectiveness and cost-effectiveness analysis.
Alexandra SavinkinaRajapaksha W M A MadushaniGolnaz Eftekhari YazdiJianing WangJoshua A BarocasJake R MorganSabrina A AssoumouAlexander Y WalleyBenjamin P LinasSean M MurphyPublished in: Addiction (Abingdon, England) (2022)
A simulation model indicates that initiation of medications for opioid use disorder and linkage policies among detox patients in Massachusetts, USA could prevent fatal opioid overdoses in the opioid use disorder population and would be cost-effective from a health-care sector perspective.
Keyphrases
- healthcare
- end stage renal disease
- public health
- palliative care
- newly diagnosed
- randomized controlled trial
- ejection fraction
- systematic review
- chronic kidney disease
- pain management
- chronic pain
- peritoneal dialysis
- prognostic factors
- mental health
- patient reported outcomes
- quality improvement
- gene expression
- dna methylation
- hepatitis c virus
- hiv testing
- men who have sex with men
- health information
- health insurance
- hiv infected
- antiretroviral therapy